NO20006041D0 - N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors - Google Patents
N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptorsInfo
- Publication number
- NO20006041D0 NO20006041D0 NO20006041A NO20006041A NO20006041D0 NO 20006041 D0 NO20006041 D0 NO 20006041D0 NO 20006041 A NO20006041 A NO 20006041A NO 20006041 A NO20006041 A NO 20006041A NO 20006041 D0 NO20006041 D0 NO 20006041D0
- Authority
- NO
- Norway
- Prior art keywords
- piperidylmethylamine
- benzodioxanylmethyl
- receptors
- affinity
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811879.7A GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
| PCT/EP1999/003648 WO1999062902A1 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006041D0 true NO20006041D0 (en) | 2000-11-29 |
| NO20006041L NO20006041L (en) | 2000-11-29 |
Family
ID=10833098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006041A NO20006041L (en) | 1998-06-03 | 2000-11-29 | N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1087964A1 (en) |
| JP (1) | JP2002517392A (en) |
| KR (1) | KR20010052526A (en) |
| CN (1) | CN1304408A (en) |
| AR (1) | AR018622A1 (en) |
| AU (1) | AU4369599A (en) |
| BG (1) | BG104988A (en) |
| BR (1) | BR9910927A (en) |
| CA (1) | CA2333756A1 (en) |
| CO (1) | CO5021190A1 (en) |
| GB (1) | GB9811879D0 (en) |
| HR (1) | HRP20010005A2 (en) |
| HU (1) | HUP0102233A2 (en) |
| ID (1) | ID27067A (en) |
| IL (1) | IL139552A0 (en) |
| NO (1) | NO20006041L (en) |
| PL (1) | PL344594A1 (en) |
| SK (1) | SK17602000A3 (en) |
| TR (1) | TR200003569T2 (en) |
| WO (1) | WO1999062902A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| GB0007376D0 (en) * | 2000-03-28 | 2000-05-17 | Knoll Ag | Therapeutic agents |
| AU2001267421A1 (en) * | 2000-05-12 | 2001-11-20 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
| ATE255578T1 (en) * | 2000-05-12 | 2003-12-15 | Solvay Pharm Bv | PIPERAZINE AND PIPERIDINE COMPOUNDS |
| GT200600078A (en) | 2005-02-17 | 2007-04-12 | DERIVATIVES OF INDOL, BENZOTIOFEN, BENZOFURAN AND CONDENSED CYCLALKYL INDEN |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681325B1 (en) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | DERIVATIVES OF AMINOMETHYL-4 PIPERIDINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
| FR2701479B1 (en) * | 1993-02-11 | 1995-05-12 | Pf Medicament | New heterocyclic derivatives of 4-aminomethyl piperidine, their preparation and their therapeutic use. |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
-
1998
- 1998-06-03 GB GBGB9811879.7A patent/GB9811879D0/en not_active Ceased
-
1999
- 1999-05-26 IL IL13955299A patent/IL139552A0/en unknown
- 1999-05-26 CN CN99806908A patent/CN1304408A/en active Pending
- 1999-05-26 EP EP99926434A patent/EP1087964A1/en not_active Ceased
- 1999-05-26 HU HU0102233A patent/HUP0102233A2/en unknown
- 1999-05-26 ID IDW20002519A patent/ID27067A/en unknown
- 1999-05-26 WO PCT/EP1999/003648 patent/WO1999062902A1/en not_active Application Discontinuation
- 1999-05-26 TR TR2000/03569T patent/TR200003569T2/en unknown
- 1999-05-26 JP JP2000552113A patent/JP2002517392A/en active Pending
- 1999-05-26 BR BR9910927-1A patent/BR9910927A/en not_active IP Right Cessation
- 1999-05-26 PL PL99344594A patent/PL344594A1/en not_active Application Discontinuation
- 1999-05-26 KR KR1020007013670A patent/KR20010052526A/en not_active Application Discontinuation
- 1999-05-26 CA CA002333756A patent/CA2333756A1/en not_active Abandoned
- 1999-05-26 SK SK1760-2000A patent/SK17602000A3/en unknown
- 1999-05-26 AU AU43695/99A patent/AU4369599A/en not_active Abandoned
- 1999-06-03 AR ARP990102619A patent/AR018622A1/en not_active Application Discontinuation
- 1999-06-03 CO CO99035020A patent/CO5021190A1/en unknown
-
2000
- 2000-11-27 BG BG104988A patent/BG104988A/en unknown
- 2000-11-29 NO NO20006041A patent/NO20006041L/en not_active Application Discontinuation
-
2001
- 2001-01-02 HR HR20010005A patent/HRP20010005A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU4369599A (en) | 1999-12-20 |
| JP2002517392A (en) | 2002-06-18 |
| CO5021190A1 (en) | 2001-03-27 |
| SK17602000A3 (en) | 2001-08-06 |
| AR018622A1 (en) | 2001-11-28 |
| PL344594A1 (en) | 2001-11-05 |
| BG104988A (en) | 2001-11-30 |
| HUP0102233A2 (en) | 2002-05-29 |
| WO1999062902A1 (en) | 1999-12-09 |
| IL139552A0 (en) | 2002-02-10 |
| CA2333756A1 (en) | 1999-12-09 |
| NO20006041L (en) | 2000-11-29 |
| BR9910927A (en) | 2001-02-20 |
| GB9811879D0 (en) | 1998-07-29 |
| EP1087964A1 (en) | 2001-04-04 |
| HRP20010005A2 (en) | 2001-12-31 |
| TR200003569T2 (en) | 2001-04-20 |
| KR20010052526A (en) | 2001-06-25 |
| CN1304408A (en) | 2001-07-18 |
| ID27067A (en) | 2001-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE227716T1 (en) | 2-SUBSTITUTED-1-PIPERIDYL-BENZIMIDAZOLE COMPOUNDS AS ORL1 RECEPTOR AGONISTS | |
| NO20004912L (en) | Compounds with effect on muscarinic receptors | |
| NO20013444L (en) | Triazole compounds with the dopamine D3 receptor affinity | |
| HK1041486A1 (en) | Oxazole compounds as prostaglandin e2 agonists or antagonists | |
| ATE331707T1 (en) | 4 PIPERAZINYLINDOL DERIVATIVES WITH AFFINITY FOR THE 5-HT6 RECEPTOR | |
| NO20010467L (en) | High affinity ligands for nociceptin receptor ORL-1 | |
| DE69921351D1 (en) | 4-AROYL-PIPERIDINE-CCR-3 RECEPTOR ANTAGONISTS III | |
| FI4209U1 (en) | New compounds | |
| IS5641A (en) | Azabicyclic 5HT1 receptors bind | |
| NO20006041D0 (en) | N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors | |
| DE69916548D1 (en) | Anti-vibration composition | |
| NO976157L (en) | Condensed thiazole derivatives with 5-HT receptor affinity | |
| DE59907696D1 (en) | filler pipe | |
| NO993172D0 (en) | Sulfonamide compounds with 5-HT receptor activity | |
| FI971854A (en) | Substituted tetracyclic axepine derivatives with 5-HT 2 receptor affinity | |
| DK1068198T3 (en) | 5-Heteroaryl substituted indoles | |
| UA28135C2 (en) | MEANS FOR MICROBIOCENOSE CORRECTION | |
| SE9800815D0 (en) | Bio-chelating agents, high affinity bio-target antagonists | |
| SE0003354D0 (en) | Materials with affinity for flavines or related compounds | |
| SI1077935T1 (en) | Phenylsulfonamide-phenylethylamines useful as dopamine receptors | |
| SE9802981D0 (en) | New tetracyclic compounds | |
| IT246012Y1 (en) | CUSHIONED SADDLE | |
| NO20013095L (en) | Arrangement for seam preparation | |
| SE9800834D0 (en) | New Compounds | |
| SE9800512D0 (en) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |